Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma (HNSCC)

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma (HNSCC). Study availability and eligibility vary by location and protocol.

32 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma (HNSCC) trial results

Active, not recruiting

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

NCT06295731

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Los Angeles Cancer Network (LACN) Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Medical Oncology Associates of San Diego San Diego, California, United States
View all 87 locations
View Trial Details
Active, not recruiting

SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

NCT03546582

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Cleveland Clinic - Weston Weston, Florida, United States
  • University of Louisville, James Graham Brown Cancer Center Louisville, Kentucky, United States
View all 18 locations
View Trial Details
Completed

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

NCT05249426

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • CTR Georges-François Leclerc Dijon, France
  • CTR Leon Berard Lyon, France
  • HOP Timone Marseille, France
View all 25 locations
View Trial Details
Completed

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

NCT04220866

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +13 more
Locations
  • UCLA Hematology & Oncology ( Site 0005) Los Angeles, California, United States
  • University of California at San Francisco ( Site 0006) San Francisco, California, United States
  • Henry Ford Hospital ( Site 0012) Detroit, Michigan, United States
  • Washington University ( Site 0021) St Louis, Missouri, United States
View all 34 locations
View Trial Details
Completed

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT04215978

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) San Diego, California, United States
  • UPMC Hillman Cancer Center (Univ Of Pittsburgh) Pittsburgh, Pennsylvania, United States
  • Blacktown Cancer And Haematology Centre Blacktown, New South Wales, Australia
View all 30 locations
View Trial Details
Completed

An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

NCT03735628

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • Tower Hematology/Oncology Medical Group Beverly Hills, California, United States
  • Orthopaedic Institute for Children Los Angeles, California, United States
  • Rocky Mountain Cancer Centers / Denver, CO Denver, Colorado, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View Trial Details
Completed

Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

NCT02764593

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Florida Cancer Center at Orlando Health Orlando, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Louisville Louisville, Kentucky, United States
View Trial Details

Related conditions